Results

Janssen Biotech Inc.

05/16/2021 | Press release | Distributed by Public on 05/16/2021 07:02

Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After[...]